Future directions in therapeutic approaches for small cell lung cancer.
Bunn
P A
PA
Lung Cancer Program, University of Colorado Cancer Center, Denver 80262, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000628:therapy*; D003131:Combined Modality Therapy; D005544:Forecasting; D006801:Humans; D000077146:Irinotecan; D008175:Lung Neoplasms / Q000188:drug therapy / Q000628:therapy*; D017239:Paclitaxel / Q000008:administration & dosage*; D059004:Topoisomerase I Inhibitors
D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D017239:Paclitaxel; D002166:Camptothecin